Navigation auf zora.uzh.ch

Search ZORA

ZORA (Zurich Open Repository and Archive)

DDOS: due to massive botnet requests against our ‘Advanced Search’ we have restricted access to UZH (local and VPN). Thank you for your understanding.

Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland

Blank, Patricia R; Szucs, Thomas D (2012). Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland. Vaccine, 30(28):4267-4275.

Abstract

The 7-valent pneumococcal conjugate vaccine (PCV7) has been shown to be highly cost-effective. The 13-valent pneumococcal conjugate vaccine (PCV13) offers seroprotection against six additional serotypes. A decision-analytic model was constructed to estimate direct medical costs and clinical effectiveness of PCV13 vaccination on invasive pneumococcal disease (IPD), pneumonia, and otitis media relative to PCV7 vaccination. The option with an one-dose catch-up vaccination in children of 15-59 months was also considered. Assuming 83% vaccination coverage and considering indirect effects, 1808 IPD, 5558 pneumonia and 74,136 otitis media cases could be eliminated from the entire population during a 10-year modelling period. The PCV13 vaccination programme would lead to additional costs (+€26.2 Mio), but saved medical costs of -€77.1 Mio due to cases averted and deaths avoided, overcompensate these costs (total cost savings -€50.9 Mio). The national immunisation programmes with PCV13 can be assumed cost saving when compared with the current vaccine PCV7 in Switzerland.

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Epidemiology, Biostatistics and Prevention Institute (EBPI)
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Life Sciences > Molecular Medicine
Life Sciences > General Immunology and Microbiology
Health Sciences > General Veterinary
Health Sciences > Public Health, Environmental and Occupational Health
Health Sciences > Infectious Diseases
Language:English
Date:2012
Deposited On:04 Dec 2012 15:03
Last Modified:07 Jun 2025 01:39
Publisher:Elsevier
Series Name:Vaccine
ISSN:0264-410X
OA Status:Green
Publisher DOI:https://doi.org/10.1016/j.vaccine.2012.04.028
PubMed ID:22521287
Download PDF  'Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland'.
Preview
  • Content: Accepted Version

Metadata Export

Statistics

Citations

Dimensions.ai Metrics
24 citations in Web of Science®
24 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

808 downloads since deposited on 04 Dec 2012
54 downloads since 12 months
Detailed statistics

Authors, Affiliations, Collaborations

Similar Publications